Insulin Resistance — What It Is, What Causes It, and How to Reverse It

Intro

Insulin resistance is a state in which the body’s cells — particularly in muscle, fat, and liver — respond less effectively to the hormone insulin. Because insulin is the key that allows glucose to enter cells and be used for energy, impaired signalling means glucose accumulates in the bloodstream. The pancreas compensates by producing more insulin, but over time this compensation fails, and blood glucose rises.

Insulin resistance is the central mechanism behind type 2 diabetes, a major driver of metabolic syndrome, and a significant contributor to cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and polycystic ovary syndrome (PCOS). It is estimated to affect more than 30% of adults in high-income countries, most of whom are undiagnosed.

Key Points

Insulin resistance is the core defect underlying type 2 diabetes — it typically precedes diagnosis by 10–15 years.
It is largely silent early on; most people are diagnosed through routine blood tests, not symptoms.
Excess visceral (abdominal) fat, physical inactivity, and poor diet are the primary drivers.
Even modest weight loss (5–7% of body weight) significantly improves insulin sensitivity.
Exercise — both aerobic and resistance training — is among the most effective interventions.
Insulin resistance is largely reversible in its early-to-moderate stages with sustained lifestyle change.

How It Develops

The development of insulin resistance follows a broadly predictable sequence:

1. Visceral fat accumulation Excess fat deposited inside the abdomen (around the liver, pancreas, and intestines) releases free fatty acids and inflammatory cytokines into the portal circulation. This directly impairs the liver’s response to insulin.

2. Hepatic insulin resistance The liver normally suppresses glucose production after meals in response to insulin. When hepatic insulin signalling is impaired, the liver continues producing glucose even when blood levels are already elevated — driving fasting hyperglycaemia.

3. Muscle insulin resistance Skeletal muscle is responsible for most glucose uptake after meals. In insulin resistance, the glucose transporter (GLUT4) fails to move to the cell surface efficiently, reducing post-meal glucose clearance.

4. Pancreatic compensation The pancreas compensates by producing more insulin. This can maintain near-normal blood glucose for years — but at the cost of progressive beta-cell exhaustion.

5. Beta-cell failure and type 2 diabetes When the pancreas can no longer compensate, blood glucose rises into the prediabetes range and eventually into the type 2 diabetes range. At the point of diabetes diagnosis, many people have already lost 50% or more of their beta-cell function.

Causes and Risk Factors

Factor	Mechanism
Excess visceral fat	Releases inflammatory signals that impair insulin signalling
Physical inactivity	Reduces GLUT4 expression in muscle; worsens glucose uptake
Excess refined carbohydrates / ultra-processed foods	Drive weight gain and hepatic fat accumulation
Poor sleep (duration or quality)	Raises cortisol; impairs glucose regulation acutely and chronically
Chronic stress	Elevated cortisol promotes visceral fat deposition
Genetic factors	Strong family history of type 2 diabetes; South and East Asian ancestry carry higher risk at lower BMI
Polycystic ovary syndrome (PCOS)	Closely associated; hormonal and metabolic interactions are bidirectional
Ageing	Gradual decline in muscle mass and hormonal milieu

Detection and Diagnosis

Insulin resistance is not diagnosed by a single test. Clinicians typically use a combination:

Routine blood tests:

Fasting glucose — elevated (≥5.6 mmol/L / 100 mg/dL) suggests impaired fasting glucose
HbA1c — reflects average blood glucose over ~3 months; ≥39 mmol/mol (5.7%) indicates prediabetes range
Fasting triglycerides — commonly elevated in insulin resistance
HDL cholesterol — typically low
Fasting insulin (less routine) — elevated fasting insulin with normal glucose is an early marker

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance): Calculated from fasting glucose and fasting insulin: HOMA-IR = (fasting insulin × fasting glucose) / 22.5. Values above 2.0–2.5 are often used as a threshold, though laboratory reference ranges vary.

Oral glucose tolerance test (OGTT): Measures glucose and sometimes insulin at 30–120 minutes after a glucose load. Captures impaired post-meal glucose handling that fasting tests may miss.

Physical signs suggesting insulin resistance:

Waist circumference — above 94 cm in men / 80 cm in women (European thresholds; lower thresholds apply for Asian populations)
Acanthosis nigricans — dark, velvety skin folds at the neck, armpits, or groin
Elevated blood pressure

What Helps: Evidence-Based Management

Weight loss

Weight loss is the most powerful intervention for improving insulin sensitivity. Fat loss — particularly visceral fat — directly reduces the inflammatory signals driving resistance.

5–7% weight loss reduces progression from prediabetes to type 2 diabetes by 40–58% (Diabetes Prevention Program)
10–15% weight loss can produce remission of type 2 diabetes in some individuals

Weight loss is not the only goal — metabolic improvements occur at relatively modest reductions.

Exercise

Exercise increases insulin sensitivity through independent mechanisms:

Aerobic exercise (brisk walking, cycling, swimming) — improves glucose uptake by stimulating GLUT4 activity during and after exercise
Resistance training — increases muscle mass, improving glucose storage capacity and baseline sensitivity
Combined training produces the largest effect

Even a single bout of moderate exercise improves insulin sensitivity for 24–48 hours. Consistent training produces durable structural benefits. 150 minutes of moderate aerobic activity per week is the evidence-based minimum.

Dietary change

No single dietary pattern has been proven superior, but consistent evidence supports:

Reducing refined carbohydrates and foods with added sugar
Minimising ultra-processed foods, which are associated with visceral fat gain and inflammation
Higher intake of dietary fibre (vegetables, legumes, whole grains) — slows glucose absorption, improves gut microbiome
Mediterranean and low-glycaemic index diets — both show consistent benefit in trials

Extreme carbohydrate restriction (ketogenic) can produce rapid improvements in fasting glucose and insulin, but long-term adherence is the limiting factor for most people.

Sleep

Sleep restriction (under 6 hours per night) acutely impairs insulin sensitivity and raises fasting glucose. Treating obstructive sleep apnoea in affected individuals improves metabolic markers. Prioritising 7–9 hours of sleep is an underutilised component of metabolic management.

Medications

When lifestyle changes are insufficient:

Metformin — improves hepatic insulin sensitivity; first-line in type 2 diabetes; can be used in prediabetes with high progression risk
GLP-1 receptor agonists (semaglutide, liraglutide) — improve insulin sensitivity through weight reduction and direct effects
SGLT2 inhibitors — reduce glucose reabsorption in the kidney; improve cardiovascular and renal outcomes in those with diabetes

FAQ

Q: Can insulin resistance be reversed? A: Yes — for most people, it is not permanent. Sustained weight loss (even 5–10%), regular exercise, and dietary improvement produce significant and sometimes complete reversal. Some people achieve full remission; others see substantial improvements that lower their long-term disease risk.

Q: What are the symptoms? A: Early insulin resistance is largely silent. Fatigue after meals, difficulty losing weight, increased hunger, and dark patches of skin (acanthosis nigricans) may appear over time. Most diagnoses come from routine blood tests.

Q: Is insulin resistance the same as prediabetes? A: They overlap but are not the same. Insulin resistance is the underlying physiological state. Prediabetes is a clinical diagnosis based on blood glucose levels. Most people with prediabetes have insulin resistance — but insulin resistance can precede prediabetes by many years.

Q: What tests diagnose it? A: No single test is routine. Fasting insulin, fasting glucose, and the HOMA-IR ratio are most commonly used. Elevated triglycerides, low HDL, and high waist circumference together strongly suggest insulin resistance.

Q: Do carbohydrates cause insulin resistance? A: Not in isolation. Excess body fat, inactivity, and caloric surplus drive the condition. Diets high in refined carbohydrates and ultra-processed foods contribute by promoting visceral fat gain — but whole food carbohydrates are handled differently.

Q: What medications help? A: Metformin is the most established. GLP-1 receptor agonists and SGLT2 inhibitors also improve insulin sensitivity and are recommended when lifestyle changes are insufficient or when other risk factors (cardiovascular disease, significant obesity) are present.

Q: Can you have insulin resistance at a normal weight? A: Yes. Insulin resistance can occur in people with a normal BMI — particularly in those of South and East Asian ancestry, who tend to accumulate visceral fat at lower body weights. Waist circumference and metabolic blood tests (fasting insulin, triglycerides, HDL cholesterol) reveal risk that BMI alone misses.

Q: How long does it take to improve insulin sensitivity? A: A single bout of moderate aerobic exercise improves insulin sensitivity for 24–48 hours. With consistent exercise and dietary change, meaningful improvements in fasting glucose, fasting insulin, and HOMA-IR are typically measurable within 8–12 weeks. Full reversal of prediabetes is possible within months to years for those who sustain the changes and achieve meaningful weight loss.